Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
29 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Sports


RSS FeedsDeignan: Chris Froome is right to race
(Cyclingnews.com)

 
 

17 february 2018 05:49:36

 
Deignan: Chris Froome is right to race
(Cyclingnews.com)
 


Ireland`s Philip Deignan (Team Sky) says he feels that teammate Chris Froome has made the right choice by opting to race this season. Froome was notified on September 20, 2017, of an adverse analytical finding (AAF) because a urine sample taken from him on stage 18 of the Vuelta a Espaņa exceeded the allowed limit of the asthma drug salbutamol. He contends he did not exceed the WADA-allowed dosage of the medication, saying that his asthma worsened during the race, and he followed his team doctor`s recommendation to increase his dose. While his case was still being reviewed by the UCI, Froome started the Ruta del Sol on Wednesday, as is allowed under UCI rules, which do not require a provisional suspension in cases of `specified substances` like salbutamol.ADVERTISEMENT There have been calls from UCI president David Lappartient, along with some riders and team managers, for Froome to step aside while his AAF for salbutamol case is resolved. But Deignan is not amongst their numbers. Like Movistar`s Mikel Landa, Deignan believes that Froome should race on. Speaking to Cyclingnews at the start of stage 2 of Ruta del Sol, where both Deignan and Froome are racing, Deignan said `Chris is totally entitled to be here. `When he`s done nothing wrong, I think it`s unfair to ask him to sit out from races, possibly six months of the year, if it takes that long to get this sorted.` You can read more at Cyclingnews.com


 
17 viewsCategory: Sports > Cycling
 
Chris Froome claims salbutamol case has been `hyped up` in media
(Cyclingnews.com)
Bahrain-Merida in driving seat for Tour of Oman queen stage
(Cyclingnews.com)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten